AABB to Present on CGT Quality Gaps at Meeting on the Mesa

Jeff Wren, MBA, CABP, AABB's vice president of biotherapies, will present on quality gaps in cell and gene therapy (CGT) delivery across today's distributed networks during the Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa.

In the AABB Innovation Spotlight, "Mind the Gap: Quality Assurance Across the CGT Network," Wren will explore how the AABB Quality Management Systems Certification can help organizations close quality gaps as CGT products move through networks of contract development and manufacturing organizations (CDMOs), testing laboratories, biorepositories and developers.

The spotlight will take place at 5:45 p.m. MT on Monday, Oct. 5. Additional information about the Meeting on the Mesa is available online.